Resmed layoffs, on the record
Every job cut, severance charge and restructuring Resmed reported in its annual reports, 2024 to 2026, quoted from the filings. Headcount went from over 9,980 to approximately 11,370.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2024 | over 9,980 | — |
| 10-K for 2025 | approximately 10,600 | June 30, 2025 |
| 10-K for 2026 | approximately 11,370 | June 30, 2026 |
Job cuts, severance and restructuring
Our summaryResMed recorded restructuring expenses tied to a review of existing operations to improve efficiency and profitability, including employee severance and one-time termination benefits.
Word for word“During the year ended June 30, 2024, we incurred restructuring expenses of $64.2 million associated with an evaluation of our existing operations to increase operational efficiency, decrease costs and increase profitability.” 10-K for 2024
Our summaryRestructuring charges for fiscal 2024 included severance and one-time termination benefits, intangible asset impairments from winding down certain business activities, and other asset impairments.
Word for word“Restructuring charges for the year ended June 30, 2024 were comprised of $28.6 million of employee severance and other one-time termination benefits, $33.2 million of intangible asset impairments associated with the wind down of certain business activities, and $2.4 million of other miscellaneous asset impairments.” 10-K for 2024
Our summaryCompany reported no material restructuring expenses in the fiscal year ended June 30, 2025.
Word for word“We did not incur material restructuring expenses during the year ended June 30, 2025.” 10-K for 2025
Our summaryThe company recorded restructuring charges for employee severance and one-time termination benefits tied to workforce planning in fiscal 2026.
Word for word“During the year ended June 30, 2026, we recorded $ 22 million of restructuring related charges for employee severance and one-time termination benefits associated with workforce planning activities.” 10-K for 2026
Our summaryIn fiscal 2024 the company recorded restructuring charges from a review of its operations aimed at greater efficiency, lower costs and higher profitability.
Word for word“During the year ended June 30, 2024, we recorded $ 64 million of restructuring related charges associated with an evaluation of our existing operations to increase operational efficiency, decrease costs and increase profitability.” 10-K for 2026
| Fiscal year ended | Restructuring charges |
|---|---|
| 2016-06-30 | $6.9 million |
| 2017-06-30 | $12.4 million |
| 2018-06-30 | $18.4 million |
| 2019-06-30 | $9.4 million |
| 2020-06-30 | $0 |
| 2021-06-30 | $8.7 million |
| 2022-06-30 | $0 |
| 2023-06-30 | $9.2 million |
| 2024-06-30 | $64.2 million |
| 2025-06-30 | $0 |
Resmed has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Resmed’s annual reports (10-K for 2026, 10-K for 2025, 10-K for 2024) and the financial data it files with the SEC, as of 2026-08-13. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.